Human medicines European public assessment report (EPAR): Cenrifki, tolebrutinib, Status: Opinion
Human medicines European public assessment report (EPAR): Itvisma, onasemnogene abeparvovec, Status: Opinion
Human medicines European public assessment report (EPAR): Palbociclib Viatris, palbociclib, Status: Opinion
Human medicines European public assessment report (EPAR): Redemplo, plozasiran, Status: Opinion
Human medicines European public assessment report (EPAR): Rexatilux, ranibizumab, Status: Opinion
Human medicines European public assessment report (EPAR): Viokat, diazoxide choline, Status: Application withdrawn
Summary of opinion: Agamree, 23/04/2026 Positive
Summary of opinion: Aquipta, 23/04/2026 Positive
Summary of opinion: Privigen, 23/04/2026 Positive
Summary of opinion: Inaqovi, 23/04/2026 Positive